Coloplast A/S (OTCMKTS:CLPBY) Reaches New 52-Week Low – Here’s Why

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY)’s stock price hit a new 52-week low during trading on Tuesday . The company traded as low as $5.65 and last traded at $5.71, with a volume of 563905 shares. The stock had previously closed at $5.75.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on CLPBY. The Goldman Sachs Group downgraded shares of Coloplast A/S from a “hold” rating to a “strong sell” rating in a report on Tuesday, April 7th. Kepler Capital Markets raised Coloplast A/S to a “strong-buy” rating in a research note on Wednesday, May 20th. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, Coloplast A/S currently has a consensus rating of “Hold”.

Coloplast A/S Trading Down 0.7%

The company has a debt-to-equity ratio of 1.50, a current ratio of 1.30 and a quick ratio of 0.81. The firm’s 50 day moving average price is $6.27 and its 200 day moving average price is $7.34. The stock has a market capitalization of $12.87 billion, a P/E ratio of 40.79, a P/E/G ratio of 1.82 and a beta of 0.18.

Coloplast A/S (OTCMKTS:CLPBY) last posted its earnings results on Tuesday, May 12th. The company reported $0.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.09 by $0.01. Coloplast A/S had a return on equity of 31.96% and a net margin of 7.46%.The company had revenue of $1.11 billion for the quarter, compared to analysts’ expectations of $1.11 billion. As a group, equities research analysts expect that Coloplast A/S Sponsored ADR will post 0.4 earnings per share for the current fiscal year.

Coloplast A/S Company Profile

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.